Medtronic PLC vs Sirius XM Holdings Inc — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Sirius XM Holdings Inc trades at $26.51 (market cap $8.87B). The key difference: Medtronic PLC is far larger — about 12.7× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (4.1%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Sirius XM Holdings Inc for 102 Days on average.
| MDT | SIRI | |
|---|---|---|
Market Cap | $112.24B | $8.87B |
Volume | 105,663,236 | 4,324,672 |
Sector | Health | Media |
52-Week High | $105.35 | $32.59 |
52-Week Low | $73.75 | $19.92 |
Typical Hold Time | 63 Days | 102 Days |
Enterprise Value | $131.58B | $18.16B |
Dividend Yield | 3.28% | 4.1% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
Sirius XM Holdings (SIRI) trades at $26.33, up 1.46% with mixed technical signals showing neutral momentum. The stock presents attractive valuation metrics with a P/E of 10.57 and P/B of 0.75, though recent earnings have been inconsistent with two misses in the last four quarters. Strong cash flow generation of $1.9B in 2025 supports the company's dividend payments and strategic initiatives, including recent YouTube advertising partnerships and technology leadership appointments.
SIRI offers value investment potential with upside to the $34.43 consensus price target, representing 31% potential return. However, investors face risks from inconsistent earnings performance and competitive pressures in the audio entertainment space. The company's improving balance sheet with debt-to-asset ratio declining to 35.63% provides financial stability, while institutional accumulation signals confidence in the turnaround story.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →